INTENDIS INC. AND TRIAX PHARMACEUTICALS, LLC ANNOUNCE CO-PROMOTION AGREEMENT

March 6, 2009

San Francisco, CA - Intendis, Inc., and Triax Pharmaceuticals, LLC announce the Co-Promotion of Locoid Lipocream® (hydrocortisone butyrate) 0.1% cream and Locoid® Lotion (hydrocortisone butyrate) 0.1% lotion at the 67th Annual Meeting of the American Academy of Dermatology. Under the co-promotion agreement, the Intendis Sales Force will promote the Locoid® products, in tandem with the Triax sales force, to dermatologists in the USA.

News Release INTENDIS INC. AND TRIAX PHARMACEUTICALS, LLC ANNOUNCE CO-PROMOTION AGREEMENT San Francisco, CA – March 6, 2009 – Intendis, Inc., and Triax Pharmaceuticals, LLC announce the Co-Promotion of Locoid Lipocream® (hydrocortisone butyrate) 0.1% cream and Locoid® Lotion (hydrocortisone butyrate) 0.1% lotion at the 67th Annual Meeting of the American Academy of Dermatology. Under the co-promotion agreement, the Intendis Sales Force

Read more

GOAMERICA BECOMES PURPLE™ COMMUNICATIONS™

February 12, 2009

NOVATO, CA - GoAmerica®, Inc., one of the nation's leading providers of text and video relay and on-site interpreting services today announced that it has changed its name to Purple™ Communications™, Inc. The Company's stock ticker has changed from NASDAQ: GOAM to NASDAQ: PRPL.

CLEARLAKE CAPITAL PARTNERS II CLOSES WITH OVER $410 MILLION IN EQUITY COMMITMENTS Name Change Marks An Important Step In a 25-Year Effort to Enhance Communication for People Who are Deaf or Hard Of Hearing Company Stock Now Trading Under Symbol NASDAQ: PRPL NOVATO, CA – February 12, 2009 – GoAmerica®, Inc., one of the nation’s leading providers of text and video

Read more

GOAMERICA® ANNOUNCES THIRD QUARTER 2008 RESULTS

November 14, 2008

NOVATO, CA - GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-of-hearing, and speech-impaired persons, today announced unaudited results for the quarter ended September 30, 2008 and the filing of its Quarterly Report on Form 10-Q with the Securities and Exchange Commission ("SEC").

CONTACTS: John Ferron GoAmerica CFO and COO [email protected] 415-408-2340 Laura Kowalcyk CJP Communications [email protected] 212-279-3115 x209   GOAMERICA® ANNOUNCES THIRD QUARTER 2008 RESULTS Continued Growth in Revenue, Margins, and Operating Profitability NOVATO, CA – November 14, 2008 – GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-of-hearing, and speech-impaired persons, today announced

Read more

GOAMERICA® ANNOUNCES SECOND QUARTER 2008 RESULTS

August 15, 2008

HACKENSACK, N.J. - GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-of-hearing, and speech-impaired persons, today announced unaudited results for the quarter ended June 30, 2008 and the filing of its Quarterly Report on Form 10-Q with the Securities and Exchange Commission ("SEC").

CONTACTS: John Ferron GoAmerica CFO and COO [email protected] 415-408-2340 Laura Kowalcyk CJP Communications [email protected] 212-279-3115 x209   GOAMERICA® ANNOUNCES SECOND QUARTER 2008 RESULTS Continues Business Integration and Synergistic Revenue Growth HACKENSACK, NJ – August 15, 2008 – GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-of-hearing, and speech-impaired persons, today announced unaudited

Read more

TRIAX PHARMACEUTICALS LAUNCHES NEW MID-POTENCY CORTICOATEROID VEHICLE, LOCOID® LOTION 0.1%

August 12, 2008

Locoid Lotion was recently introduced at the Summer American Academy of Dermatology Meeting, in Chicago, Illinois, for the treatment of mild-to-moderate atopic dermatitis in pediatric to adult patients. Triax Pharmaceuticals, LLC, the marketers of Locoid Lipocream (hydrocortisone butyrate 0.1%) a leading mid-potency brand in corticosteroids, recently launched the new product to cover larger and hairy affected areas with an elegant, non-greasy application to treat atopic dermatitis.

TRIAX PHARMACEUTICALS LAUNCHES NEW MID-POTENCY CORTICOSTEROID VEHICLE, LOCOID® LOTION 0.1% Locoid Lotion was recently introduced at the Summer American Academy of Dermatology Meeting, in Chicago, Illinois, for the treatment of mild-to-moderate atopic dermatitis in pediatric to adult patients. Triax Pharmaceuticals, LLC, the marketers of Locoid Lipocream (hydrocortisone butyrate 0.1%) a leading mid-potency brand in corticosteroids, recently launched the new product

Read more

SIGN LANGUAGE ASSOCIATES AND VISUAL LANGUAGE INTERPRETING COMBINE WITH GOAMERICA TO FORM NATION’S PREMIER SIGN LANGUAGE INTERPRETING SERVICES COMPANY

July 1, 2008

WASHINGTON, DC - GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-ofhearing, and speech-disabled persons, today announced a merger with two of the nation's premier sign language interpreting services firms: Sign Language Associates (SLA) and Visual Language Interpreting (VLI), both of which are based in the Washington, D.C. metro area.

CONTACT: GoAmerica Laura Kowalcyk CJP Communications [email protected] 212-279-3115 x209   SIGN LANGUAGE ASSOCIATES AND VISUAL LANGUAGE INTERPRETING COMBINE WITH GOAMERICA TO FORM NATION’S PREMIER SIGN LANGAUAGE INTERPRETING SERVICES COMPANY WASHINGTON, DC – July 1, 2008 – GoAmerica, Inc. (NASDAQ: GOAM), a provider of relay and wireless communications and professional interpreter services for deaf, hard-of- hearing, and speech-disabled persons, today announced

Read more

GOAMERICA® ANNOUNCES FIRST QUARTER 2008 RESULTS

May 15, 2008

HACKENSACK, N.J. -- GoAmerica, Inc. (Nasdaq:GOAM) , a provider of relay and wireless communications and professional interpreter services for deaf, hard-of-hearing, and speech-disabled persons, today announced unaudited results for the quarter ended March 31, 2008. The Company's Quarterly Report on Form 10-Q is on file with the Securities and Exchange Commission ("SEC").

CONTACTS: John Ferron GoAmerica COO [email protected] 707-658-4690 Laura Kowalcyk CJP Communications [email protected] 212-279-3115 x209   GOAMERICA® ANNOUNCES FIRST QUARTER 2008 RESULTS Completes Strategic Business Transactions and Achieves Operating Profitability HACKENSACK, NJ – May 15, 2008 – GoAmerica, Inc. (Nasdaq:GOAM) , a provider of relay and wireless communications and professional interpreter services for deaf, hard- of-hearing, and speech-disabled persons, today announced unaudited

Read more

GOAMERICA® APPOINTS INDUSTRY LEADING TECHNOLOGIST TO BOARD OF DIRECTORS

March 20, 2008

HACKENSACK, N.J. - GoAmerica, Inc. (NASDAQ: GOAM), a provider of communications services for people who are deaf, hard-of-hearing, or speechdisabled, today announced the appointment of Chris Gibbons to its Board of Directors.

CONTACTS: GoAmerica Laura Kowalcyk Cubitt Jacobs & Prosek [email protected] 212-279-3115 x209   GOAMERICA® APPOINTS INDUSTRY LEADING TECHNOLOGIST TO BOARD OF DIRECTORS HACKENSACK, NJ – March 20, 2008 – GoAmerica, Inc. (NASDAQ: GOAM), a provider of communications services for people who are deaf, hard-of-hearing, or speech- disabled, today announced the appointment of Chris Gibbons to its Board of Directors. Gibbons is an

Read more

CLEARLAKE CAPITAL ANNOUNCES COMPLETION OF $70 MILLION INVESTMENT IN GOAMERICA

January 21, 2008

NEW YORK, NY - Clearlake Capital Group (together with its affiliates, "Clearlake"), an investment firm that integrates private equity, leveraged finance and special-situations investing, today announced that it led $125 million in financing for GoAmerica, Inc.

CONTACTS: Carol Makovich Owen Blicksilver PR (203) 622-4781 Joanne Lessner Owen Blicksilver PR (212) 222-7436   CLEARLAKE CAPITAL ANNOUNCES COMPLETION OF $70 MILLION INVESTMENT IN GOAMERICA Led $125 Million Investment with Debt Financing from Churchill Financial and Ableco Finance; Represents Latest Investment from Clearlake’s Inaugural Fund NEW YORK, NY – January 21, 2008 – Clearlake Capital Group (together with its

Read more

COMPUDYNE CORPORATION ANNOUNCES COMPLETION OF SALE TO GORES PATRIOT HOLDINGS, INC.

September 21, 2007

ANNAPOLIS, Md., /PRNewswire-FirstCall/ -- CompuDyne Corporation (Nasdaq: CDCY) announced today the completion of the merger of the Company with Patriot Acquisition Corp., an affiliate of The Gores Group, LLC.

COMPUDYNE CORPORATION ANNOUNCES COMPLETION OF SALE TO GORES PATRIOT HOLDINGS, INC. ANNAPOLIS, MD – September 21, 2007 – CompuDyne Corporation (Nasdaq: CDCY) announced today the completion of the merger of the Company with Patriot Acquisition Corp., an affiliate of The Gores Group, LLC. Gores Patriot Holdings, Inc. completed the acquisition of CompuDyne Corporation pursuant to the short-form merger procedure available

Read more